These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

794 related articles for article (PubMed ID: 27160704)

  • 61. Identification of human embryonic stem cell surface markers by combined membrane-polysome translation state array analysis and immunotranscriptional profiling.
    Kolle G; Ho M; Zhou Q; Chy HS; Krishnan K; Cloonan N; Bertoncello I; Laslett AL; Grimmond SM
    Stem Cells; 2009 Oct; 27(10):2446-56. PubMed ID: 19650036
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Alternative Routes to Induced Pluripotent Stem Cells Revealed by Reprogramming of the Neural Lineage.
    Jackson SA; Olufs ZP; Tran KA; Zaidan NZ; Sridharan R
    Stem Cell Reports; 2016 Mar; 6(3):302-11. PubMed ID: 26905202
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
    Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
    Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reprogramming of somatic cells after fusion with induced pluripotent stem cells and nuclear transfer embryonic stem cells.
    Sumer H; Jones KL; Liu J; Heffernan C; Tat PA; Upton KR; Verma PJ
    Stem Cells Dev; 2010 Feb; 19(2):239-46. PubMed ID: 19637940
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular signature and colony morphology affect in vitro pluripotency of porcine induced pluripotent stem cells.
    Setthawong P; Phakdeedindan P; Techakumphu M; Tharasanit T
    Reprod Domest Anim; 2021 Aug; 56(8):1104-1116. PubMed ID: 34013645
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative transcriptomic analysis identifies reprogramming and differentiation genes differentially expressed in UiPSCs and ESCs.
    Shi L; Cui Y; Zhou X; Luan J; Wang L; Han J
    Biosci Trends; 2017 Jul; 11(3):355-359. PubMed ID: 28529265
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Post-irradiation promotes susceptibility to reprogramming to pluripotent state in human fibroblasts.
    Lee SB; Han SH; Kim MJ; Shim S; Shin HY; Lee SJ; Kim HW; Jang WS; Seo S; Jang S; Lee Y; Park S
    Cell Cycle; 2017; 16(21):2119-2127. PubMed ID: 28902577
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Parallel derivation of isogenic human primed and naive induced pluripotent stem cells.
    Kilens S; Meistermann D; Moreno D; Chariau C; Gaignerie A; Reignier A; Lelièvre Y; Casanova M; Vallot C; Nedellec S; Flippe L; Firmin J; Song J; Charpentier E; Lammers J; Donnart A; Marec N; Deb W; Bihouée A; Le Caignec C; Pecqueur C; Redon R; Barrière P; Bourdon J; Pasque V; Soumillon M; Mikkelsen TS; Rougeulle C; Fréour T; David L;
    Nat Commun; 2018 Jan; 9(1):360. PubMed ID: 29367672
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High-resolution analysis with novel cell-surface markers identifies routes to iPS cells.
    O'Malley J; Skylaki S; Iwabuchi KA; Chantzoura E; Ruetz T; Johnsson A; Tomlinson SR; Linnarsson S; Kaji K
    Nature; 2013 Jul; 499(7456):88-91. PubMed ID: 23728301
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Derivation of novel naive-like porcine embryonic stem cells by a reprogramming factor-assisted strategy.
    Zhang M; Wang C; Jiang H; Liu M; Yang N; Zhao L; Hou D; Jin Y; Chen Q; Chen Y; Wang J; Dai Y; Li R
    FASEB J; 2019 Aug; 33(8):9350-9361. PubMed ID: 31125263
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative epigenetic evaluation of human embryonic stem and induced pluripotent cells.
    Favaedi R; Shahhoseini M; Pakzad M; Mollamohammadi S; Baharvand H
    Int J Dev Biol; 2016; 60(4-6):103-10. PubMed ID: 27389983
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cell surface marker mediated purification of iPS cell intermediates from a reprogrammable mouse model.
    Nefzger CM; Alaei S; Knaupp AS; Holmes ML; Polo JM
    J Vis Exp; 2014 Sep; (91):e51728. PubMed ID: 25225958
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nuclear transcriptome profiling of induced pluripotent stem cells and embryonic stem cells identify non-coding loci resistant to reprogramming.
    Fort A; Yamada D; Hashimoto K; Koseki H; Carninci P
    Cell Cycle; 2015; 14(8):1148-55. PubMed ID: 25664506
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Surface marker epithelial cell adhesion molecule and E-cadherin facilitate the identification and selection of induced pluripotent stem cells.
    Chen HF; Chuang CY; Lee WC; Huang HP; Wu HC; Ho HN; Chen YJ; Kuo HC
    Stem Cell Rev Rep; 2011 Sep; 7(3):722-35. PubMed ID: 21305366
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Screening for epigenetic target genes that enhance reprogramming using lentiviral-delivered shRNA.
    Rim JS; Strickler K; Barnes C; Harkins L; Staszkiewicz J; Power R; Eilertsen KJ
    Methods Mol Biol; 2011; 702():299-316. PubMed ID: 21082411
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current status in cancer cell reprogramming and its clinical implications.
    Izgi K; Canatan H; Iskender B
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) at naïve state.
    Wang Y; Zhao C; Hou Z; Yang Y; Bi Y; Wang H; Zhang Y; Gao S
    Elife; 2018 Jan; 7():. PubMed ID: 29381138
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reprogramming of chimpanzee fibroblasts into a multipotent cancerous but not fully pluripotent state by transducing iPSC factors in 2i/LIF culture.
    Lin ZY; Nakai R; Hirai H; Kozuka D; Katayama S; Nakamura SI; Okada S; Kitajima R; Imai H; Okano H; Imamura M
    Differentiation; 2020; 112():67-76. PubMed ID: 32045848
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diversity of dermal fibroblasts as major determinant of variability in cell reprogramming.
    Sacco AM; Belviso I; Romano V; Carfora A; Schonauer F; Nurzynska D; Montagnani S; Di Meglio F; Castaldo C
    J Cell Mol Med; 2019 Jun; 23(6):4256-4268. PubMed ID: 30980516
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dissecting direct reprogramming through integrative genomic analysis.
    Mikkelsen TS; Hanna J; Zhang X; Ku M; Wernig M; Schorderet P; Bernstein BE; Jaenisch R; Lander ES; Meissner A
    Nature; 2008 Jul; 454(7200):49-55. PubMed ID: 18509334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.